SkinnyRx vs MEDVi 2026
Two compounded GLP-1 telehealth providers compared. MEDVi pricing is fully Gronk-verified — $179/mo entry, highest brand search volume in our stack. SkinnyRx is a recognized program in the space, but pricing requires direct verification before we can present a fair side-by-side.
At a Glance
SkinnyRx
Pricing — VERIFYBest for: TBD pending pricing verification
SkinnyRx is an established telehealth brand in the compounded GLP-1 space. We cannot confirm current pricing from our available data — all cost figures require direct verification at skinnyrx.com before you can meaningfully compare.
- Telehealth-based GLP-1 program
- Compounded semaglutide offered
- Pricing not confirmed — VERIFY at skinnyrx.com
- Tirzepatide availability not confirmed
- Affiliate program pending Katalys approval
MEDVi
Editor’s PickBest for: lowest verified price + highest brand trust
MEDVi has the highest organic brand-search volume of any provider in our stack (33K monthly) and Gronk-verified pricing from $179/mo. If you want confirmed numbers before starting an intake, MEDVi delivers that clearly.
- Semaglutide from $179/mo (Gronk-verified)
- Tirzepatide $229–$299/mo (Gronk-verified)
- 33,000 monthly brand searches — largest patient base signal
- Physician-supervised, cancel anytime
Full Side-by-Side
MEDVi data is Gronk-verified May 2026. SkinnyRx cells marked VERIFY require direct confirmation at skinnyrx.com.
| Dimension | SkinnyRx | MEDVi |
|---|---|---|
| Compounded Semaglutide — entry price | VERIFY (not confirmed as of May 2026) | $179/mo (range $179–$249/mo) |
| Compounded Tirzepatide | VERIFY (availability not confirmed) | $229–$299/mo (Gronk-verified) |
| Metabolic bloodwork included | VERIFY | Not included (standard for this tier) |
| Physician consult included | VERIFY | Yes |
| Cancel anytime | VERIFY | Yes |
| State availability | VERIFY (telehealth, state coverage unknown) | Most U.S. states (confirm at intake) |
| Brand search volume (Ahrefs) | Moderate (specific volume data pending) | ~33,000/mo on "medvi" — highest in our stack |
| Affiliate program status | Pending Katalys ($500 CPA potential, not yet active) | Pending Katalys (offer #1265, $228 CPA) |
| Editorial pick | No — pending pricing verification | Yes — verified pricing + highest brand trust |
| Pricing verification status | NOT VERIFIED — check skinnyrx.com directly | Gronk-verified May 2026 |
MEDVi Pricing — Verified
Compounded Semaglutide
$179/mo
$179–$249/mo
Not included
Verified on Gronk May 6, 2026Compounded Tirzepatide
$229–$299/mo
Not included
Verified on Gronk May 6, 2026Why we can’t show SkinnyRx pricing here
Our data integrity rule: we only publish pricing that has been Gronk-verified or confirmed via an active affiliate program data source. SkinnyRx did not return confirmed pricing data through either channel as of May 2026. Rather than publish a number we can’t stand behind, we flag it for direct verification. This policy protects you from making enrollment decisions based on stale or incorrect cost data. Visit skinnyrx.com directly, complete their intake questionnaire, and compare the actual quote against MEDVi’s confirmed $179/mo entry price.
Why Brand Search Volume Matters
When comparing telehealth GLP-1 providers, organic brand search volume is one of the few objective proxies for established patient base and consumer trust. A program with 33,000 monthly searches on its brand name is sending a clear market signal.
Highest in our provider stack (Ahrefs, May 2026)
Gronk-verified May 2026 — lowest mid-tier starting rate in our stack
Not confirmed via Gronk or Katalys — visit skinnyrx.com for your quote
Who Should Pick Which?
Pick MEDVi if:
- You want verified, transparent pricing before starting an intake — MEDVi’s $179/mo is Gronk-confirmed and available upfront.
- You want the provider with the largest established patient base signal (33K monthly brand searches) as a trust proxy.
- You want access to both compounded semaglutide and tirzepatide on a single platform.
- You already have baseline labs from a PCP and don’t need them bundled into the program.
Consider SkinnyRx if:
- You’ve seen SkinnyRx recommended elsewhere and want to evaluate it directly — visit skinnyrx.com, complete their intake, and compare the quote you receive against MEDVi’s $179/mo.
- Their pricing, when verified, comes in meaningfully below MEDVi’s confirmed rate at your dose tier.
Our Verdict
MEDVi is our editorial pick for this comparison. The case is straightforward: Gronk-verified pricing from $179/mo, the highest organic brand search volume in our provider stack (33K monthly), and a complete mid-tier program covering both semaglutide and tirzepatide. We can recommend it with confidence because the numbers are confirmed.
SkinnyRx is not disqualified — it is unverified. We cannot publish pricing data we cannot stand behind. When our verification is complete (or when you check skinnyrx.com directly), compare SkinnyRx’s actual quote against MEDVi’s $179/mo. If SkinnyRx comes in lower at your target dose and includes equivalent services, that gap matters.
For patients who want to start a verified program today, MEDVi is the clear choice based on currently available data.
Frequently Asked Questions
Which is cheaper, SkinnyRx or MEDVi?
MEDVi is the only provider in this comparison with confirmed pricing. MEDVi compounded semaglutide starts at $179/mo (full range $179–$249/mo) and compounded tirzepatide runs $229–$299/mo — both Gronk-verified May 2026. SkinnyRx pricing is not confirmed through our direct verification process as of May 2026 and requires visiting their site for a current quote. We cannot make a direct price comparison without confirmed SkinnyRx data — pick MEDVi if verified pricing upfront is important to you.
Which has the better GLP-1 program, SkinnyRx or MEDVi?
Based on verified data, MEDVi is our editorial pick. MEDVi offers Gronk-verified pricing, the highest brand search volume in our provider stack (33,000 monthly searches for "medvi"), and a physician-supervised program covering both semaglutide and tirzepatide. SkinnyRx is a recognized telehealth brand in the GLP-1 space, but our team has not been able to confirm their current pricing via direct crawl or Gronk verification — all SkinnyRx fields in our comparison require direct verification at skinnyrx.com. If you want to compare them apples-to-apples, get a quote from SkinnyRx and compare it against MEDVi's published $179/mo starting rate.
Is SkinnyRx available in all states?
SkinnyRx availability by state requires direct verification at skinnyrx.com — telehealth availability varies by provider and changes as state regulations evolve. As of our last review (May 2026), we do not have confirmed state-by-state coverage data for SkinnyRx. MEDVi is available in most U.S. states, but confirm your specific state during their intake process. Both providers operate via telehealth, meaning coverage depends on where licensed prescribers are active in their network.
Does MEDVi or SkinnyRx include bloodwork?
MEDVi does not include labs in its standard pricing — consistent with most mid-tier compounded GLP-1 platforms. SkinnyRx's included services require direct verification; we cannot confirm whether their program includes lab monitoring as of May 2026. If metabolic bloodwork as a program inclusion is important to you, Eden Health is a verified option that explicitly includes a comprehensive metabolic panel at $229–$249/mo for semaglutide.
Why is MEDVi the editorial pick over SkinnyRx?
MEDVi is our editorial pick in this comparison for two reasons: verified pricing and brand trust. MEDVi's $179–$299/mo range is Gronk-verified (May 2026), so we can present concrete numbers. MEDVi also has the highest brand search volume of any provider in our stack at 33,000 monthly searches — a meaningful proxy for established patient volume and consumer confidence. SkinnyRx is a real program, but without confirmed pricing data we cannot endorse it with the same specificity. When verification is complete, we will update this page. Note: SkinnyRx carries a potential $500 CPA on Katalys pending approval, which is above-average for this category — we disclose this in our affiliate disclosure.
What does the MEDVi program include?
MEDVi's compounded GLP-1 program includes a physician consultation, prescription for compounded semaglutide or tirzepatide, and ongoing support. Semaglutide starts at $179/mo (range $179–$249/mo depending on dose tier); tirzepatide runs $229–$299/mo. The program does not include baseline labs in the standard pricing tier — patients who want lab monitoring would need to arrange that separately through their PCP or a service like Eden Health. MEDVi supports cancellation at any time and is available in most U.S. states via telehealth. All pricing Gronk-verified May 2026.
Related comparisons
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.